CLINICAL_TRIALS
trial_result
· 2020-04-28
Clinical Trial Update: A Study of LY900014 Formulation in Participants With Type 1 Diabetes Mellitus Using Insulin Pumps [Phase 1]
Summary
Phase 1 trial evaluating LY900014 formulation in participants with Type 1 diabetes using insulin pumps has completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Eli Lilly and Company | Conditions: Diabetes Mellitus, Type 1 | Phase 1 | Status: COMPLETED | Results posted: 2020-04-28